Fig. 7

Evaluation of HA-RM-Cel-BR targeting in vivo. In vivo fluorescence imaging of the joints at different time points after intravenous injection of Free DIR, Cel-BR@DIR, and HA-RM-Cel-BR@DIR (a), and ex vivo fluorescence distribution in heart, liver, spleen, lungs, kidneys, and joints (b)